150 related articles for article (PubMed ID: 2694229)
1. Can the pattern of neuropsychological improvement obtained with cholinergic drugs be used to infer a cholinergic mechanism in other nootropic drugs?
Gainotti G; Nocentini U; Sena E
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S47-59. PubMed ID: 2694229
[TBL] [Abstract][Full Text] [Related]
2. A clinical and neurophysiological trial on nootropic drugs in patients with mental decline.
Gallai V; Mazzotta G; Del Gatto F; Montesi S; Mazzetti A; Dominici P; Della Monica A
Acta Neurol (Napoli); 1991 Feb; 13(1):1-12. PubMed ID: 1867125
[TBL] [Abstract][Full Text] [Related]
3. Piracetam combined with lecithin in the treatment of Alzheimer's disease.
Growdon JH; Corkin S; Huff FJ; Rosen TJ
Neurobiol Aging; 1986; 7(4):269-76. PubMed ID: 3528889
[TBL] [Abstract][Full Text] [Related]
4. Double-blind placebo-controlled, neuropsychological and neurophysiological investigations with oxiracetam (CGP 21690E) in memory-impaired patients with epilepsy.
Aldenkamp AP; van Wieringen A; Alpherts WC; van Emde Boas W; Haverkort HA; de Vries J; Meinardi H
Neuropsychobiology; 1990-1991; 24(2):90-101. PubMed ID: 2134116
[TBL] [Abstract][Full Text] [Related]
5. A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.
Sano M; Stern Y; Marder K; Mayeux R
Mov Disord; 1990; 5(3):230-4. PubMed ID: 2388639
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree.
Villardita C; Grioli S; Lomeo C; Cattaneo C; Parini J
Neuropsychobiology; 1992; 25(1):24-8. PubMed ID: 1603291
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacologic correction of learning and memory disorders induced by exposure to high-frequency electromagnetic radiation].
Krylov IN; Iasnetsov VV; Dukhanin AS; Pal'tsev IuP
Biull Eksp Biol Med; 1993 Mar; 115(3):260-2. PubMed ID: 8054613
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic approaches to the treatment of Alzheimer's disease.
Hollander E; Mohs RC; Davis KL
Br Med Bull; 1986 Jan; 42(1):97-100. PubMed ID: 3006861
[No Abstract] [Full Text] [Related]
9. A double blind investigation of piracetam (Nootropil) vs placebo in geriatric memory.
Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):49-56. PubMed ID: 360232
[TBL] [Abstract][Full Text] [Related]
10. Declarative memory.
Riedel WJ; Blokland A
Handb Exp Pharmacol; 2015; 228():215-36. PubMed ID: 25977084
[TBL] [Abstract][Full Text] [Related]
11. Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning.
Gainotti G; Benedetti N; Caltagirone C; Nocentini U
Clin Neuropharmacol; 1986; 9 Suppl 3():S65-9. PubMed ID: 3297320
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of memory loss in the geriatric patient.
Galizia VJ
Drug Intell Clin Pharm; 1984 Oct; 18(10):784-91. PubMed ID: 6149111
[TBL] [Abstract][Full Text] [Related]
13. Treatment trial of oxiracetam in Alzheimer's disease.
Green RC; Goldstein FC; Auchus AP; Presley R; Clark WS; Van Tuyl L; Green J; Hersch SM; Karp HR
Arch Neurol; 1992 Nov; 49(11):1135-6. PubMed ID: 1444879
[TBL] [Abstract][Full Text] [Related]
14. Measurement of cholinergic drug effects on memory in Alzheimer's disease.
Brinkman SD; Gershon S
Neurobiol Aging; 1983; 4(2):139-45. PubMed ID: 6355883
[TBL] [Abstract][Full Text] [Related]
15. [A comparative study of the nootropic properties of piracetam and oxiracetam].
Krylova IN; Antonova LV; Kamenskiĭ AA; Iasnetsov VV
Farmakol Toksikol; 1991; 54(1):14-6. PubMed ID: 1860490
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of oxiracetam therapy in the treatment of cognitive deficiencies secondary to primary degenerative dementia.
Rozzini R; Zanetti O; Bianchetti A
Acta Neurol (Napoli); 1992 Apr; 14(2):117-26. PubMed ID: 1414555
[TBL] [Abstract][Full Text] [Related]
17. [Use of preparations from the nootropic group for treating memory disorders in chronic alcoholism].
Shabanov PD; Grinenko AIa; Kalishevich SIu
Klin Med (Mosk); 1988 Sep; 66(9):114-6. PubMed ID: 3204950
[No Abstract] [Full Text] [Related]
18. A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
Bagadia VN; Gada MT; Mundra VK; Simon S; Doshi JM; Pradhan PV; Shah LP; Sheth UK
J Postgrad Med; 1980 Apr; 26(2):116-20. PubMed ID: 7012328
[No Abstract] [Full Text] [Related]
19. Clinical evaluation of compounds for the treatment of memory dysfunction.
Growdon JH; Corkin S; Huff FJ
Ann N Y Acad Sci; 1985; 444():437-49. PubMed ID: 3893272
[No Abstract] [Full Text] [Related]
20. Verbal memory.
Sumiyoshi T
Handb Exp Pharmacol; 2015; 228():237-47. PubMed ID: 25977085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
